SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-23-000091
Filing Date
2023-11-06
Accepted
2023-11-06 20:29:02
Documents
1
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1699320532.html 4  
1 FORM 4 wk-form4_1699320532.xml 4 3933
  Complete submission text file 0001516551-23-000091.txt   5609
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O 5AM VENTURES 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address
Schwab Andrew J. (Reporting) CIK: 0001598549 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55136 | Film No.: 231381261